Alan Crane, M.B.A. – Chairman and CEO of Momenta Pharmaceuticals, Inc.

Mr. Crane is the former Chief Executive Officer of Momenta Pharmaceuticals, a biotechnology company headquartered in Cambridge, MA. Mr. Crane was also previously Senior Vice President, Global Corporate Development, at Millennium Pharmaceuticals where he was responsible for leading Millennium's strategic partnering, mergers and acquisitions, and licensing activities. During his tenure, Mr. Crane built one of the industry's leading corporate development groups, forged strategic alliances that brought over $2 billion of funding to Millennium, and licensed or acquired 19 products. Prior to this Mr. Crane was a marketing executive at Dupont-Merck and a consultant with the Boston Consulting Group and Arthur D. Little.

Albert Friedberg, M.B.A. – President and CEO of Friedberg Mercantile Group

Mr. Friedberg has served as a director and Chairman of the Board of Vaccinex since the Company's inception. Mr. Friedberg is the CEO and President of Friedberg Mercantile Group, a Toronto-based commodities and investment management firm he founded in 1971. He served as Chairman of the Toronto Futures Exchange from March 1985 to June 1988. Mr. Friedberg was educated at Johns Hopkins University and Columbia University, where he received an M.B.A. in International Banking.

Bala Manian, Ph.D. – Founder of ReaMetrix

Dr. Manian is a serial entrepreneur having in the past 30 years founded (and/or co-founded) Quantum Dot Corporation, Surromed, Entigen, Biometric Imaging, Lumisys Inc., Molecular Dynamics, Digital Optics Corporation and, his latest venture, ReaMetrix. An expert in the design of electro-optical systems, Dr. Manian holds more than 30 patents, many of which have resulted in successful commercial products and has authored more than 35 peer reviewed scientific publications. He has a B.S. in Physics from the University of Madras, an M.S. in Applied Optics from the University of Rochester, and a Ph.D. in mechanical engineering from Purdue University. He is a member of the Board of Trustees of University of Rochester and a board member of Biocon, Ltd. of Bangalore, India.

Gerald VanStrydonck, M.B.A. – CFO of InSciTek Microsystems

Mr. VanStrydonck is the Chief Financial Officer of InSciTek Microsystems, an information technology firm located in Rochester, NY. He is also a former Managing Partner of PricewaterhouseCoopers, LLP. Mr. VanStrydonck has over 30 years of tax and financial consulting experience and has been involved in the development of a number of companies. He received his M.B.A. from the State University of New York at Buffalo.

Maurice Zauderer, Ph.D. – President and CEO of Vaccinex, Inc.

Dr. Zauderer co-founded Vaccinex and has served as President, Chief Executive Officer and a director of Vaccinex since its inception. He is the inventor of core technologies for construction of representative cDNA libraries in vaccinia virus and discovery of fully human monoclonal antibodies. Prior to founding Vaccinex, Dr. Zauderer was a Professor at the University of Rochester and has also held faculty appointments at Columbia University. During his academic career, Dr. Zauderer held the position of visiting scientist at the Laboratory of Cell Biology (Rome, Italy), the Ontario Cancer Institute (Toronto, Canada), and at the National Cancer Institute (Bethesda, Maryland). Dr. Zauderer holds a Ph.D. in cell biology from the Massachusetts Institute of Technology. He is also a member of the board of directors of the New York Biotechnology Association (NYBA).